Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - exemestane 25mg;   - film coated tablet - 25 mg - active: exemestane 25mg   excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate mannitol microcrystalline cellulose opadry white y-1-7000 polysorbate 80 sodium starch glycolate - mestane is indicated for: · the adjuvant treatment of postmenopausal women with oestrogen receptor positive or receptor unknown early breast cancer after initial adjuvant tamoxifen to reduce the risk of recurrence (distant and loco-regional) and contralateral breast cancer.

Ирландия - английский - HPRA (Health Products Regulatory Authority)

accord healthcare limited - exemestane - film coated tablet - 25 milligram - exemestane

Соединенные Штаты - английский - NLM (National Library of Medicine)

a-s medication solutions - exemestane (unii: ny22hmq4bx) (exemestane - unii:ny22hmq4bx) - exemestane is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy [see clinical studies ( 14.1 )] . exemestane is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy [see clinical studies ( 14.2 )] . exemestane tablets are contraindicated in patients with a known hypersensitivity to the drug or to any of the excipients. risk summary based on findings in animal studies and its mechanism of action, exemestane can cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)] . limited human data from case reports are insufficient to inform a drug-associated risk. in animal reproduction studies, administration of exemestane to pregnant rats and rabbits caused increased incidence of abo

Ирландия - английский - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - exemestane - film-coated tablet - 25 milligram(s) - aromatase inhibitors; exemestane

Ирландия - английский - HPRA (Health Products Regulatory Authority)

teva b.v. - exemestane - film-coated tablet - aromatase inhibitors; exemestane

Австралия - английский - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; hypromellose; mannitol; microcrystalline cellulose; magnesium stearate; crospovidone; polysorbate 80; titanium dioxide; macrogol 400 - exemestane is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . exemestane is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Канада - английский - Health Canada

genmed a division of pfizer canada ulc - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents

Канада - английский - Health Canada

teva canada limited - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents

Канада - английский - Health Canada

generic medical partners inc - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents

Канада - английский - Health Canada

teva canada limited - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents